The effect of oral polyphosphate and nitrilotriacetic acid on experimental rat urolithiasis.
D000085:Acetates / Q000494:pharmacology*; D000818:Animals; D002614:Chelating Agents / Q000627:therapeutic use*; D007669:Kidney Calculi / Q000139:chemically induced / Q000517:prevention & control*; D008274:Magnesium / Q000378:metabolism; D009570:Nitriles / Q000494:pharmacology*; D010710:Phosphates / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000494:pharmacology*
D000085:Acetates; D002614:Chelating Agents; D009570:Nitriles; D010710:Phosphates; D012964:Sodium; D008274:Magnesium